Treatment for Gonorrhea Arthritis (Disseminated Gonococcal Infection)
Initial Treatment
- The American College of Physicians recommends initiating treatment with ceftriaxone 1 g IV or IM every 24 hours PLUS azithromycin 1 g orally as a single dose, continuing parenteral therapy until clinical improvement, then transitioning to oral cefixime 400 mg twice daily to complete 7 days of total therapy, with a strength of evidence based on clinical guidelines 1, 2
- The Centers for Disease Control and Prevention suggests adding azithromycin 1 g orally as a single dose on day 1 to address potential chlamydial coinfection and provide dual antimicrobial coverage to combat resistance, with a strength of evidence based on clinical trials 1, 2
Transition to Oral Therapy
- The MMWR Recommendations and Reports recommend switching to cefixime 400 mg orally twice daily to complete a total of 7 days of antimicrobial therapy, with a strength of evidence based on clinical guidelines 3
- The total duration of therapy should be 7 days for uncomplicated gonococcal arthritis, or 10-14 days if meningitis is documented, with a strength of evidence based on clinical guidelines 3
Alternative Regimens
- For patients with severe cephalosporin allergy, the American College of Physicians recommends using azithromycin 2 g orally as a single dose with mandatory test-of-cure at 1 week, though this has lower efficacy and high gastrointestinal side effects, with a strength of evidence based on clinical trials 1, 2
- Consider gentamicin 240 mg IM single dose PLUS azithromycin 2 g orally as an alternative, though gentamicin has poor efficacy for pharyngeal infections, with a strength of evidence based on clinical trials 2
Partner Management and Follow-Up
- The Centers for Disease Control and Prevention recommends evaluating and treating all sexual partners from the preceding 60 days with the same dual therapy regimen, with a strength of evidence based on clinical guidelines 1, 2
- Instruct patients to avoid sexual intercourse until therapy is completed and both patient and partners are asymptomatic, with a strength of evidence based on clinical guidelines 1
- Test for HIV and syphilis at the time of gonorrhea diagnosis, as gonorrhea facilitates HIV transmission, with a strength of evidence based on clinical trials 2
Special Populations
- For pregnant women, the American College of Obstetricians and Gynecologists recommends using ceftriaxone 1 g IV/IM daily plus azithromycin 1 g orally, with a strength of evidence based on clinical guidelines 2
- For neonates with disseminated gonococcal infection, the MMWR Recommendations and Reports recommend using ceftriaxone 25-50 mg/kg/day IV or IM for 7 days, with a strength of evidence based on clinical guidelines 3
Treatment Failure Management
- If symptoms persist after 48-72 hours of appropriate therapy, obtain culture with antimicrobial susceptibility testing immediately, with a strength of evidence based on clinical guidelines 2
- Report suspected treatment failure to local public health officials within 24 hours, with a strength of evidence based on clinical guidelines 2